TMCI
Treace Medical Concepts IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$127.63M
P/E Ratio
—
EPS
$-0.93
Beta
0.88
52W High
$7.78
52W Low
$1.17
50-Day MA
$1.66
200-Day MA
$4.14
Dividend Yield
—
Profit Margin
-27.70%
Forward P/E
—
PEG Ratio
—
About Treace Medical Concepts Inc
Treace Medical Concepts, Inc., an orthopedic medical device company, is dedicated to the design, manufacture, and marketing of biological devices and / or solutions for foot and ankle surgeons in the United States. The company is headquartered in Ponte Vedra Beach, Florida.
Fundamentals
| Revenue (TTM) | $212.69M |
| Gross Profit (TTM) | $169.75M |
| EBITDA | $-44.53M |
| Operating Margin | -9.47% |
| Return on Equity | -58.90% |
| Return on Assets | -16.60% |
| Revenue/Share (TTM) | $3.36 |
| Book Value | $1.37 |
| Price-to-Book | 1.46 |
| Price-to-Sales (TTM) | 0.60 |
| EV/Revenue | 0.711 |
| EV/EBITDA | -40.95 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -9.00% |
| Shares Outstanding | $64.78M |
| Float | $47.95M |
| % Insiders | 24.79% |
| % Institutions | 55.48% |
Historical Volatility
HV 10-Day
151.93%
HV 20-Day
115.37%
HV 30-Day
118.82%
HV 60-Day
102.84%
HV Rank
87.7%
Volatility is currently expanding
Analyst Ratings
Consensus ($4.25 target)
1
Buy3
Hold1
Strong SellData last updated: 4/21/2026